[go: up one dir, main page]

Human Rabies Treatment-From Palliation to Promise

Viruses. 2024 Jan 22;16(1):160. doi: 10.3390/v16010160.

Abstract

Rabies encephalitis has plagued humankind for thousands of years. In developed countries, access to preventive care, both pre-exposure and post-exposure, has significantly reduced the burden of suffering and disease. However, around the world, rabies remains a neglected tropical disease, largely due to uncontrolled dog rabies, and tens of thousands perish each year. Currently, the standard of care for management of rabies encephalitis is palliation. Heroic attempts to treat human rabies patients over the last few decades have yielded glimpses into our understanding of pathophysiology, opening the door to the development of new antiviral therapies and modalities of treatment. Researchers continue to investigate new compounds and approaches to therapy, yet there remain real challenges given the complexity of the disease. We explore and review some of the promising therapies on the horizon in pursuit of a salvage treatment for rabies.

Keywords: antiviral agents; encephalitic rabies; lyssavirus; rabies.

Publication types

  • Review

MeSH terms

  • Animals
  • Dogs
  • Encephalitis*
  • Humans
  • Rabies Vaccines*
  • Rabies virus*
  • Rabies* / drug therapy
  • Rabies* / prevention & control
  • Zoonoses / prevention & control

Substances

  • Rabies Vaccines

Grants and funding

This research received no external funding.